Gwangju, South Korea

In-Hyun Lee

This inventor holds 5 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Dae Hwa Pharma. Co., Ltd., Daehwa Pharm. Co., Ltd.. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: In-Hyun Lee. Retrieved from https://idiyas.com/inventor/in-hyun-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 58(Granted Patents)


Location History:

  • Seoul, KR (2011)
  • Gwangju, KR (2020 - 2021)

Company Filing History:


Years Active: 2011-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: In-Hyun Lee: Innovator in Pharmaceutical Compositions

Introduction

In-Hyun Lee is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral compositions that incorporate taxanes. With a total of five patents to his name, Lee's work is recognized for its innovative approaches to drug formulation.

Latest Patents

Among his latest patents, one includes a pharmaceutical composition for oral administration comprising taxane. This composition features a combination of a taxane, medium chain triglycerides, an oleoyl glycerol complex, a surfactant, and optionally, polyoxyl glyceryl fatty acid ester. Another notable patent focuses on a high concentration taxane composition, which includes specific percentages of taxane, medium chain triglycerides, monooleoyl glycerol, surfactants, and polyoxyl glyceryl fatty acid ester. These inventions aim to enhance the efficacy and delivery of taxane-based medications.

Career Highlights

In-Hyun Lee has worked with reputable companies in the pharmaceutical industry, including Dae Hwa Pharma Co., Ltd. and Daehwa Pharm Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and innovations.

Collaborations

Lee has collaborated with several professionals in his field, including Yeong-Taek Park and Min-Hee Son. These collaborations have likely enriched his research and development efforts, leading to advancements in pharmaceutical compositions.

Conclusion

In-Hyun Lee's contributions to pharmaceutical innovations, particularly in taxane compositions, highlight his role as a significant inventor in the industry. His patents reflect a commitment to improving drug delivery systems and enhancing patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…